Phase II study of extended-dose temozolomide in patients with melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18467721

J. Clin. Oncol. 2008 May 10 26 14 2299-304

Download in:

View as

Triples

General Info

PMID
18467721